Observing the effects of Diquasol eye drops on dry eye syndrome
Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops and Hyaluron/Hyaluronmax Eye Drops in Patients Over 19 Years Old With Dry Eye Syndrome
Hanlim Pharm. Co., Ltd. · NCT06172530
This study is testing how well Diquasol eye drops can help adults with dry eye syndrome feel better over 12 weeks.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Hanlim Pharm. Co., Ltd. (industry) |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06172530 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the efficacy and safety of Diquasol eye drops in treating dry eye syndrome. It will assess prescription patterns in clinical practice and monitor changes in symptoms, treatment satisfaction, and intraocular tolerance over a 12-week period. Patients will receive Diquasol either alone or in combination with Hyaluron or Hyaluronmax eye drops. The study will involve adults aged 19 and older who meet specific inclusion criteria.
Who should consider this trial
Good fit: Ideal candidates include adults aged 19 and older with dry eye syndrome and a tear break-up time of 10 seconds or less.
Not a fit: Patients who are pregnant, lactating, or contraindicated for the eye drops used in the study will not benefit.
Why it matters
Potential benefit: If successful, this study could improve treatment options and satisfaction for patients suffering from dry eye syndrome.
How similar studies have performed: Other studies have shown positive outcomes with similar treatments for dry eye syndrome, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 19 years and older * Patients with dry eye syndrome with TBUT of 10 or less * Individuals scheduled to receive either Diquasol eye drops as a monotherapy or a combination therapy of Diquasol eye drops with Hyaluron eye drops or Diquasol eye drops with Hyaluronmax eye drops, based on clinical judgment for the treatment of dry eye syndrome * Individuals who have voluntarily provided written consent for participation in this study Exclusion Criteria: * Pregnant or lactating women * Individuals contraindicated according to the approval conditions of Diquasol eye drops, Hyaluron eye drops, and Hyaluronmax eye drops * Cases where the principal investigator or study personnel deem the individual unsuitable for participation in this clinical study
Where this trial is running
Seoul
- CK St. Mary's Eye Clinic — Seoul, Korea, Republic of (RECRUITING)
Study contacts
- Principal investigator: ChounKi Joo — CK st. Mary's Eye Clinic
- Study coordinator: Sol Jo
- Email: ssoljo@hanlim.com
- Phone: +82-2-3489-6299
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Dry Eye Syndrome